As described elsewhere (Biotechnol Bioeng 2010, 2013), our DXB11 (dhfr–) host cell engineering strategy achieved high cell viability for a prolonged period (more than 1 month) and enhanced mAb productivity (\u3e100 pg/cell/day) by nutritional control. Introduction of taurine transporter (TAUT) into DXB11 parent cells increased glutamine uptake and accelerated glutathione metabolism. By forcing the overexpression of TAUT, we were able to control DXB11 host cell functions and thereby increase the monoclonal antibody (mAb) titer up to 8.1 g/L/31 days under conventional 1-L bioreactor fed-batch conditions. Furthermore, the mAb produced by the DXB11/TAUT cells was comparable in quality to the mAb produced by the parent cells.
In this study, we used CHO-K1 host cells and a chemically defined medium (CDM) for the development of cell lines producing recycling antibodies (rcAb). CDM adaptation and TAUT overexpression improved CHO-K1 cell performance. Rapid-growth CHO-K1/TAUT cells were developed, and these enabled the establishment of strains that produced higher yields of rcAb than did CHO-K1 parent cell (p \u3c 0.05). Viable cell density of these CHO-K1/TAUT/rcAb strains increased not only under shaker passage culture conditions (p \u3c 0.01) but also under shaker fed-batch culture conditions (p \u3c 0.01).
These results suggest that our TAUT overexpression strategy also has a unique potential for the improvement of CHO-K1 host cells as well as DXB11 host cells
